275 related articles for article (PubMed ID: 31492621)
41. [A case of mucocutaneous leishmaniasis treated with success with a low dose of pentavalent antimonial].
Amato VS; de Oliveira LS; Silva AC; Machado FR; Amato JG; Nicodemo AC; Amato Neto V
Rev Soc Bras Med Trop; 1998; 31(2):221-4. PubMed ID: 9608241
[TBL] [Abstract][Full Text] [Related]
42. A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: Levamisole in combination with Glucantime in field and laboratory models.
Bamorovat M; Sharifi I; Fekri A; Keyhani A; Aflatoonian MR; Heshmatkhah A; Oliaee RT; Khosravi A; Naderi A; Parizi MH; Mostafavi M; Varma RS
Microb Pathog; 2019 Mar; 128():162-170. PubMed ID: 30583021
[TBL] [Abstract][Full Text] [Related]
43. Disseminated Leishmaniasis, a Severe Form of Leishmania braziliensis Infection.
Machado PRL; Lago A; Cardoso TM; Magalhaes A; Carvalho LP; Lago T; Carvalho AM; Costa R; Carvalho EM
Emerg Infect Dis; 2024 Mar; 30(3):510-518. PubMed ID: 38407142
[TBL] [Abstract][Full Text] [Related]
44. Meglumine antimoniate was associated with a higher cure rate than liposomal amphotericin B in the treatment of American tegumentary leishmaniasis: A retrospective cohort study from a
Barroso DH; Gonçalves RT; Barbosa JS; da Motta JOC; Freire GSM; Gomes CM; Sampaio RNR
Front Cell Infect Microbiol; 2022; 12():993338. PubMed ID: 36211958
[TBL] [Abstract][Full Text] [Related]
45. Tongue Nodule as Primary Manifestation of American Cutaneous Leishmaniasis in an Immunocompetent Patient.
Botelho MCB; Ferreira LL; Fikaris S; Prado-Ribeiro AC; Soubhia AMP; Biasoli ER; Miyahara GI; Bernabé DG
Head Neck Pathol; 2021 Sep; 15(3):1069-1073. PubMed ID: 33372239
[TBL] [Abstract][Full Text] [Related]
46. Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs.
Hadighi R; Boucher P; Khamesipour A; Meamar AR; Roy G; Ouellette M; Mohebali M
Parasitol Res; 2007 Oct; 101(5):1319-22. PubMed ID: 17610079
[TBL] [Abstract][Full Text] [Related]
47. Differential expression of TLRs 2, 4, 9, iNOS and TNF-α and arginase activity in peripheral blood monocytes from glucantime unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis caused by Leishmania tropica.
Oliaee RT; Sharifi I; Afgar A; Jafarzadeh A; Kareshk AT; Bamorovat M; Sharifi H; Babaei Z; Keyhani A; Keyhani A; Abedi L; Sharifi F
Microb Pathog; 2019 Jan; 126():368-378. PubMed ID: 30399441
[TBL] [Abstract][Full Text] [Related]
48. A randomized, open-label clinical trial comparing the long-term effects of miltefosine and meglumine antimoniate for mucosal leishmaniasis.
Sampaio RNR; Silva JSFE; Paula CDR; Porto C; Motta JOCD; Pereira LIA; Martins SS; Barroso DH; Freire GSM; Gomes CM
Rev Soc Bras Med Trop; 2019 Mar; 52():e20180292. PubMed ID: 30942258
[TBL] [Abstract][Full Text] [Related]
49. Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profiling.
Oliaee RT; Sharifi I; Afgar A; Kareshk AT; Asadi A; Heshmatkhah A; Bamorovat M; Jafarzadeh A; Mohammadi MA; Daneshvar H
Trop Med Int Health; 2018 Jun; 23(6):622-633. PubMed ID: 29709098
[TBL] [Abstract][Full Text] [Related]
50. Drug hypersensitivity syndrome induced by meglumine antimoniate.
Jeddi F; Caumes E; Thellier M; Jauréguiberry S; Mazier D; Buffet PA
Am J Trop Med Hyg; 2009 Jun; 80(6):939-40. PubMed ID: 19478253
[TBL] [Abstract][Full Text] [Related]
51. Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice.
Solgi G; Kariminia A; Abdi K; Darabi M; Ghareghozloo B
Korean J Parasitol; 2006 Mar; 44(1):55-61. PubMed ID: 16514283
[TBL] [Abstract][Full Text] [Related]
52. Pilot study of safety and efficacy of topical liposomal amphotericin B for cutaneous leishmaniasis caused by Leishmania major in Islamic Republic of Iran.
Khamesipour A; Mohammadi A; Jaafari M; Eskandari S; Tasbihi M; Javadi A; Afshari F; Mortazavi H; Firooz A
East Mediterr Health J; 2022 Sep; 28(9):658-663. PubMed ID: 36205204
[TBL] [Abstract][Full Text] [Related]
53. Disseminated American muco-cutaneous leishmaniasis caused by Leishmania braziliensis braziliensis in a patient with AIDS: a case report.
Machado ES; Braga Mda P; Da Cruz AM; Coutinho SG; Vieira AR; Rutowitsch MS; Cuzzi-Maya T; Grimaldi júnior G; Menezes JA
Mem Inst Oswaldo Cruz; 1992; 87(4):487-92. PubMed ID: 1343662
[TBL] [Abstract][Full Text] [Related]
54. Treatment of mucocutaneous leishmaniasis - A systematic review.
Fischer T; Fischer M; Schliemann S; Elsner P
J Dtsch Dermatol Ges; 2024 Jun; 22(6):763-773. PubMed ID: 38769082
[TBL] [Abstract][Full Text] [Related]
55. Mucosal leishmaniasis ("espundia" Escomel, 1911).
Marsden PD
Trans R Soc Trop Med Hyg; 1986; 80(6):859-76. PubMed ID: 3037735
[TBL] [Abstract][Full Text] [Related]
56. Lip leishmaniasis: a case series with molecular identification and literature review.
Mohammadpour I; Motazedian MH; Handjani F; Hatam GR
BMC Infect Dis; 2017 Jan; 17(1):96. PubMed ID: 28122496
[TBL] [Abstract][Full Text] [Related]
57. [Histopathology of cutaneous leishmaniasis caused by Leishmania braziliensis braziliensis. 4. Histopathological classification].
de Magalhães AV; Moraes MA; Raick AN; Llanos-Cuentas A; Costa JM; Cuba CC; Marsden PD
Rev Inst Med Trop Sao Paulo; 1986; 28(6):421-30. PubMed ID: 3602829
[No Abstract] [Full Text] [Related]
58. Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group.
Laguna F; López-Vélez R; Pulido F; Salas A; Torre-Cisneros J; Torres E; Medrano FJ; Sanz J; Picó G; Gómez-Rodrigo J; Pasquau J; Alvar J
AIDS; 1999 Jun; 13(9):1063-9. PubMed ID: 10397536
[TBL] [Abstract][Full Text] [Related]
59. [A case of urticaria during pentavalent antimony use in a patient with mucous leishmaniasis].
Oliveira MR; Marsden PD
Rev Soc Bras Med Trop; 1995; 28(3):287. PubMed ID: 7480927
[No Abstract] [Full Text] [Related]
60. Mucosal Leishmaniasis of the lip: Report of an Exuberant case in a Young man.
de Arruda JAA; Tomo S; Cunha JLS; Guevara JR; Martínez I; Reyes O; Bracho V; Sanchez C; de Andrade BAB; Villarroel-Dorrego M
Head Neck Pathol; 2023 Jun; 17(2):540-545. PubMed ID: 36346574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
